US FDA approves Merck's injectable version of blockbuster cancer therapy Keytruda
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Merck & Co. (NYSE: MRK) | Delayed: 145.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.60 | 52 Week High | $65.46 | |||
| Open | $145.60 | 52 Week Low | $47.97 | |||
| Day High | $145.60 | P/E | 99.05 | |||
| Day Low | $145.60 | EPS | $1.47 | |||
| Volume | 4,192 | |||||
